CohBar Inc.

(COB.U:CX2)

By |

Profile

CohBar Inc is a biotechnology company. It is primarily engaged in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drug such as CB4209 and CB4211, SHLP-6, SHLP-2 and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operation of the group is functioned through the region of United States.

Contact Information

Website: www.cohbar.com
Email: jeff.biunno@cohbar.com
Main Phone: +1 650 446-7888
Address: 1455 Adams Drive
Address 2: Suite 2050
State: CA
City / Town: Menlo Park
Country: USA
Postal Code: 94025

Issuer Information

Exchange: CDX
CEO: Simon Allen
Employees: 10
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange TSXV